rs727503407
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate
The NM_000335.5(SCN5A):c.3659C>T(p.Ala1220Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000472 in 1,610,910 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.3662C>T | p.Ala1221Val | missense_variant | Exon 20 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.3659C>T | p.Ala1220Val | missense_variant | Exon 20 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3662C>T | p.Ala1221Val | missense_variant | Exon 20 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.3659C>T | p.Ala1220Val | missense_variant | Exon 20 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247618Hom.: 1 AF XY: 0.0000149 AC XY: 2AN XY: 133996
GnomAD4 exome AF: 0.0000507 AC: 74AN: 1458776Hom.: 1 Cov.: 31 AF XY: 0.0000565 AC XY: 41AN XY: 725284
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:2
The SCN5A c.3662C>T; p.Ala1221Val variant (rs727503407) is reported in the literature in three individuals affected with long QT syndrome (Blaufox 2012, Itoh 2016), but also in a healthy individual (Aguib 2020). This variant is also listed in ClinVar (Variation ID: 165141) and is found in the general population with an overall allele frequency of 0.001% (3/247618 alleles, including 1 homozygote) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is deleterious (REVEL: 0.854). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Aguib Y et al. The Egyptian Collaborative Cardiac Genomics (ECCO-GEN) Project: defining a healthy volunteer cohort. NPJ Genom Med. 2020 Oct 23;5:46. PMID: 33110626. Blaufox AD et al. Congenital long QT 3 in the pediatric population. Am J Cardiol. 2012 May 15;109(10):1459-65. PMID: 22360817. Itoh H et al. Asymmetry of parental origin in long QT syndrome: preferential maternal transmission of KCNQ1 variants linked to channel dysfunction. Eur J Hum Genet. 2016 Aug;24(8):1160-6. PMID: 26669661. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 22360817, 29420653) -
Cardiac arrhythmia Uncertain:2
This missense variant replaces alanine with valine at codon 1221 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in a few individuals affected with long QT syndrome (PMID: 22360817, 26669661), as well as in a healthy individual (Aguib et al., 2019). This variant has been identified in 3/247618 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This missense variant replaces alanine with valine at codon 1221 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in a few individuals affected with long QT syndrome (PMID: 22360817, 26669661), as well as in a healthy individual (Aguib et al., 2019). This variant has been identified in 3/247618 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The Ala1221Val variant in SCN5A has been reported in 1 individual with Long QT s yndrome (Blaufox 2012). Data from large population studies is insufficient to as sess the frequency of this variant. Computational prediction tools and conservat ion analysis do not provide strong support for or against an impact to the prote in. Additional information is needed to fully assess the clinical significance o f the Ala1221Val variant. -
Brugada syndrome Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1221 of the SCN5A protein (p.Ala1221Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with long QT syndrome (PMID: 22360817). ClinVar contains an entry for this variant (Variation ID: 165141). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.A1221V variant (also known as c.3662C>T), located in coding exon 19 of the SCN5A gene, results from a C to T substitution at nucleotide position 3662. The alanine at codon 1221 is replaced by valine, an amino acid with similar properties. This variant has been detected in long QT syndrome cohorts; however, clinical details were limited (Blaufox AD et al. Am. J. Cardiol., 2012 May;109:1459-65; Itoh H et al. Eur J Hum Genet, 2016 08;24:1160-6). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at